IN8bio Inc. (NASDAQ: INAB) Stock Information | RedChip

IN8bio Inc. (NASDAQ: INAB)


$0.85
-0.0080 ( -0.93% ) 44.3K

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

Market Data


Open


$0.85

Previous close


$0.86

Volume


44.3K

Market cap


$38.79M

Day range


$0.83 - $0.87

52 week range


$0.65 - $2.48

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jun 14, 2024
4 Insider transactions 1 Jun 14, 2024
4 Insider transactions 1 Jun 14, 2024
4 Insider transactions 1 Jun 14, 2024
4 Insider transactions 1 Jun 14, 2024
4 Insider transactions 1 Jun 14, 2024
4 Insider transactions 1 Jun 14, 2024
8-k 8K-related 15 Jun 13, 2024
8-k 8K-related 15 Jun 03, 2024
8-k 8K-related 13 May 09, 2024

Latest News